NDC 21695-079

Methocarbamol

Methocarbamol

Methocarbamol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp.. The primary component is Methocarbamol.

Product ID21695-079_2e5d447c-a50c-4905-b56f-32fe86824dd9
NDC21695-079
Product TypeHuman Prescription Drug
Proprietary NameMethocarbamol
Generic NameMethocarbamol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1976-08-18
Marketing CategoryANDA / ANDA
Application NumberANDA085123
Labeler NameRebel Distributors Corp.
Substance NameMETHOCARBAMOL
Active Ingredient Strength750 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-079-90

90 TABLET in 1 BOTTLE (21695-079-90)
Marketing Start Date1976-08-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-079-07 [21695007907]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-90 [21695007990]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-00 [21695007900]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-20 [21695007920]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-12 [21695007912]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-60 [21695007960]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-30 [21695007930]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1976-08-18
Inactivation Date2019-09-24

NDC 21695-079-40 [21695007940]

Methocarbamol TABLET
Marketing CategoryANDA
Application NumberANDA085123
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-06-28
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL750 mg/1

OpenFDA Data

SPL SET ID:41a6a652-046e-4780-9c6b-000363def056
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197943
  • 197944

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Methocarbamol" or generic name "Methocarbamol"

    NDCBrand NameGeneric Name
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    68071-1874MethocarbamolMethocarbamol
    68071-4365MethocarbamolMethocarbamol
    68071-4458MethocarbamolMethocarbamol
    68071-4505MethocarbamolMethocarbamol
    68083-317MethocarbamolMethocarbamol
    68084-056MethocarbamolMethocarbamol
    68071-4520MethocarbamolMethocarbamol
    68084-057MethocarbamolMethocarbamol
    68151-2775MethocarbamolMethocarbamol
    68387-340MethocarbamolMethocarbamol
    68387-342MethocarbamolMethocarbamol
    68475-002MethocarbamolMethocarbamol
    68788-6391MethocarbamolMethocarbamol
    68788-9076MethocarbamolMethocarbamol
    68788-9075MethocarbamolMethocarbamol
    68788-9388MethocarbamolMethocarbamol
    68788-9768MethocarbamolMethocarbamol
    68788-9376MethocarbamolMethocarbamol
    69543-134MethocarbamolMethocarbamol
    69543-135MethocarbamolMethocarbamol
    70010-754MethocarbamolMethocarbamol
    70069-101MethocarbamolMethocarbamol
    70010-770MethocarbamolMethocarbamol
    70518-0024MethocarbamolMethocarbamol
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.